Top 3 Global Agricultural Companies Going Public... US Investment Banks 'Anxious'

Goldman, JP Morgan Lobby for Syngenta IPO
US Sanctions Investments in Chinese Military-Linked Firms
Impact of China Sanctions Threatens Lead Underwriter Participation

Syngenta, the world's third-largest agricultural technology company, is preparing for a mainboard listing (equivalent to Korea's KOSPI) on the Shanghai Stock Exchange, while American investment firms are showing signs of anxiety. They face the risk of being unable to participate as underwriters in Syngenta's IPO due to U.S. government sanctions against China.

On the 27th, major foreign media reported that American investment banks such as Goldman Sachs and JP Morgan Chase are concerned about not securing rights related to Syngenta's IPO.

Syngenta is considered a major player in this year's Chinese IPO market. The amount of funds to be raised through this listing reaches $9 billion (11.7495 trillion KRW), making it the fourth-largest IPO in the history of the Chinese stock market. Syngenta is recognized as a global agricultural technology company, ranking first worldwide in crop protection sectors such as herbicides and pesticides. Previously, after being acquired by ChemChina, China's largest chemical company, Syngenta attempted to list on the STAR Market, China's version of Nasdaq, but changed its listing destination to the Shanghai Stock Exchange mainboard due to concerns over the IPO size being too large.

American banks such as Goldman Sachs are known to have played a significant role in Syngenta's IPO process. Citing multiple financial sources, major foreign media reported, "Goldman Sachs, JP Morgan Chase, Morgan Stanley, and UBS Group, Switzerland's largest investment bank, have been lobbying to take leading roles in Syngenta's listing process," adding, "An IPO roadshow may begin within a few weeks." Additionally, Western investment firms are showing great interest in whether Syngenta will pursue secondary listings in London and New York.

American investment bank Goldman Sachs

However, U.S. government sanctions have emerged as an obstacle. The previous Trump administration designated ChemChina, Huawei, Sinochem, and others as companies owned or controlled by the Chinese military and signed executive orders banning investments by U.S. companies in them. Although Syngenta is not included in the list of restricted investment companies, experts believe it will not be easy for U.S. firms to participate as underwriters in this IPO.

Benjamin Coste Reje, a former legal counsel at the U.S. Trade Representative's office, told major foreign media, "The U.S. political sphere is trying to prevent domestic companies from investing in firms related to the Chinese military," adding, "In such circumstances, involvement in the IPO could lead to investigations by policymakers."

Following this news, investors are hesitating to subscribe to the public offering. An official from an Asian bank said, "We are considering participating in the public offering subscription," but added, "We have doubts about whether this issue can ultimately be resolved, so we will not go all-in during the investment process."

This content was produced with the assistance of AI translation services.